O. Y. Bayer Et Al. , "Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma," JOURNAL OF ASTHMA , vol.59, no.3, pp.580-589, 2022
Bayer, O. Y. Et Al. 2022. Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma. JOURNAL OF ASTHMA , vol.59, no.3 , 580-589.
Bayer, O. Y., Türktaş, İ., Karagol, H. İ., Soysal, S., & Yapar, D., (2022). Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma. JOURNAL OF ASTHMA , vol.59, no.3, 580-589.
Bayer, Oznur Et Al. "Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma," JOURNAL OF ASTHMA , vol.59, no.3, 580-589, 2022
Bayer, Oznur Y. Et Al. "Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma." JOURNAL OF ASTHMA , vol.59, no.3, pp.580-589, 2022
Bayer, O. Y. Et Al. (2022) . "Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma." JOURNAL OF ASTHMA , vol.59, no.3, pp.580-589.
@article{article, author={Oznur Yilmaz Bayer Et Al. }, title={Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma}, journal={JOURNAL OF ASTHMA}, year=2022, pages={580-589} }